Drug Database
Back to search

Belgium· BE-AMP-SAM213324-00

Orgalutran 0.25 mg/0.5 ml

A ganirelix product containing ganirelix, registered in Belgium by Organon. The same ATC class is registered in 17 of our 19 countries.

ATC H01CC01

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedOrgalutran 0.25 mg/0.5 mlATCH01CC01REGISTER NO.BE-AMP-SAM213324-00PACKS LISTED3CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ganirelixAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Ganirelix is registered in 17 of 19 countries.

Countries holding a registration under ATC H01CC01 (ganirelix), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 10 of them publish a price we can compare per daily dose
Search ganirelix products by name

Ganirelix · ATC H01CC01

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Ganirelix
Manufacturer
Organon
Country
Belgium (BE)
ATC code
H01CC01
ATC class
Ganirelix
Defined daily dose
0.25 mg, P
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 3

  • be_apb
    1557800
  • be_apb
    1557792
  • be_apb
    4743175

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

7 interactions on record for ganirelix.

Graded by severity as the source publishes them — 7 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check ganirelix against other medicinesHow interaction checks work

Ganirelix · interactions on record

7 records

  • 7 moderate

Most severe, free to view

  • Chorionic gonadotrophinG03GA01moderate
  • Menotropin HMGG03GA02moderate
  • UrofollitropinG03GA04moderate
  • GonadorelinH01CA01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ganirelix in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ganirelix products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Austria · Ganirelix Astro, Ganirelix Theramex
  • Bulgaria · Ganirelix Theramex
  • Czechia · Fyremadel
  • Germany · Fyremadel, Ganiran
  • Denmark · Fyremadel, Ganirelix Orifarm
  • Estonia · Ganirelix Theramex
  • Spain · Astarté, Fyremadel
  • Finland · Fyremadel, Ganirelix Orifarm
  • France · Fyremadel, Ganirelix Eg
  • United Kingdom (Northern Ireland) · Fyremadel
  • Greece · Fyremadel, Ovamex
  • Croatia · Ganireliks Theramex
  • Hungary · Ganirelix Theramex
  • Iceland · Ganirelix, Ganirelix Gedeon Richter
  • Italy · Fyremadel, Ovamex
  • Liechtenstein · Ganirelix, Ganirelix Gedeon Richter
  • Lithuania · Ganirelix Theramex
  • Latvia · Ganirelix Theramex
  • Netherlands · Fyremadel, Ganirelix Fagron
  • Norway · Fyremadel, Ganirelix
  • Poland · Fyremadel, Ovamex
  • Portugal · Astarté, Fyremadel
  • Sweden · Fyremadel, Ganirelix Orifarm
  • Slovenia · Ganireliks Theramex
  • Slovakia · Fyremadel, Ganirelix Theramex

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f440df71-e70a-48aa-8006-c47f07c866d0
GET /v1/drugs/f440df71-e70a-48aa-8006-c47f07c866d0?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for injection",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Orgalutran 0.25 mg/0.5 ml",
  "name_fr": "Orgalutran 0.25 mg/0.5 ml",
  "name_nl": "Orgalutran 0.25 mg/0.5 ml",
  "amp_code": "SAM213324-00",
  "strengths": [
    "0.5000"
  ],
  "pack_count": 3,
  "substances": [
    "Ganirelix"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Ganirelix",
  "authorisation_numbers": [
    "EU/1/00/130/001",
    "EU/1/00/130/002"
  ]
}
API referenceMCP serverPlans

See everything about ganirelix.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console